This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction: Remission of Anxiety-Related Disorders

Richard C. Shelton, MD

Published: October 1, 2001

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

For several years, the relative degree of response to treatment of depressive disorders has been the focus of intense discussion.1-3 For example, a consensus group convened nearly a decade ago to develop definitions for terms such as treatment response and remission, as well as relapse and recurrence of illness.4 The development of such concepts has allowed the field to focus on the important notion of achieving and maintaining full symptomatic (i.e., "syndromal") response in depression.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Anxiety , Anxiolytics


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...